Trials / Unknown
UnknownNCT04015791
NOCISCAN-Lumbar Spine (LS) Clinical Evaluation Study
Clinical Evaluation of NOCISCAN-Lumbar Spine (LS) Disc MR Spectroscopy (MRS) for Diagnosis of Discogenic Low Back Pain and Correlation With Surgical Outcomes
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 240 (estimated)
- Sponsor
- Nocimed, LLC · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
A prospective, double blinded, multi-center study to assess the validity and clinical utility of the pre-operative NOCISCAN-LS software in the identification of painful lumbar discs, and the correlation with improved surgical outcomes at 3, 6, 12 and 24 months (follow-up) following spine surgery in a single enrollment arm of subjects with chronic symptomatic single level degenerative disc disease (DDD) at L3 to S1, but with two evaluation groups- Match Group and Miss Group,of subjects based on the association between the NOCISCORE results of treated and untreated disc levels.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | NOCISCAN-LS Disc MR Spectroscopy | The investigational Nociscan Suite is a software suite that works with existing high field MR systems and MRS pulse sequence via and optimized protocol to conduct MRS exam of lumbar discs. The software suite post-processes the NOCISCAN-LS disc MRS exam data to calculate ratios of spectroscopic signals at regions along the MRS frequency spectrum associated with certain chemicals that change with degeneration and pain |
Timeline
- Start date
- 2023-04-01
- Primary completion
- 2024-09-30
- Completion
- 2025-12-31
- First posted
- 2019-07-11
- Last updated
- 2022-07-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04015791. Inclusion in this directory is not an endorsement.